未找到相关数据
Relationship between PD-L1 expression and clinical outcomes in patients with advanced gastric cancer treated with the anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) in KEYNOTE-012
被引：49
作者：
Bang, Yung-Jue
Chung, Hyun-Choel
Shankaran, Veena
Geva, Ravit
Catenacci, Daniel Virgil Thomas
Gupta, Shilpa
Eder, Joseph Paul
Berger, Raanan
Gonzalez, Edward J.
Ray, Archana
Dolled-Filhart, Marisa
Emancipator, Kenneth
Pathiraja, Kumudu
Lunceford, Jared K.
Cheng, Jonathan D.
Koshiji, Minori
Muro, Kei
机构：
[1] Seoul Natl Univ Coll Med, Seoul, South Korea
[2] Yonsei Univ Coll Med, Yonsei Canc Ctr, Seoul, South Korea
[3] Univ Washington Sch Med, Div Med Oncol, Seattle, WA USA
[4] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel
[5] Univ Chicago, Chicago, IL 60637 USA
[6] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[7] Yale Canc Ctr, New Haven, CT USA
[8] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
[9] Merck & Co Inc, Kenilworth, NJ USA
[10] Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.4001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4001
引用
收藏
页数：1
相关论文